Bladder Cancer
European Bladder Cancer Therapeutics Market Participants Must Explore New Areas of Drug Development to Offset Impact of Mature Product Lines
Published in Oncology Business Week, October 21st, 2007
This Frost & Sullivan research titled European Bladder Cancer Therapeutics Markets presents a concise analysis of the market that includes challenges, factors driving growth and the revenue forecasts from 2003 to 2013. The study identifies the competitive opportunities within the market as well as strategies to exploit these opportunities and overcome industry challenges. In this research, Frost & Sullivan's expert analysts thoroughly examine the cytotoxic (chemotherapy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Bioengineering
SAFC Supports Potent API Conjugate Manufacturing With New St. Louis Production Suite - Biomedicine
New Scientists Boost Disease-based Research at Boston Biomedical Research Institute - Biomedicine
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog - Brain Cancer
Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement - Breast Cancer
ADVISORY/Safeway Unveils State-of-the-Art Mobile Mammography Unit at Breast Cancer Awareness Town Hall - Breast Cancer
America's Bakers Can Help Bake for the Cure(TM) in ACH Food Companies' Partnership with Susan G. Komen for the Cure - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
